EPA Finalizes Cancellation of Dacthal Over Health Concerns for Unborn Babies

October 25, 2024 | Source: DrugWatch | by Christian Simmons

The Environmental Protection Agency (EPA) has finalized its cancellation of Dacthal, just months after it issued a historic suspension to halt the use and sales of the pesticide.

Dacthal, also known as DCPA, has been connected to adverse health effects in unborn babies when pregnant mothers are exposed to it.

“With the final cancellation of DCPA, we’re taking a definitive step to protect pregnant women and their unborn babies,” Michal Freedhoff, Assistant Administrator for the Office of Chemical Safety and Pollution Prevention, said in a statement.

“The science showing the potential for irreversible harm to unborn babies’ developing brains, in addition to other lifelong consequences from exposure, demands decisive action to remove this dangerous chemical from the marketplace,” said Freedhoff.

Lawyers have begun to investigate potential Dacthal lawsuits involving those who were exposed to the pesticide. There are concerns about its impact on thyroid hormone levels in unborn infants, which is linked to impaired motor skills, decreased IQ and other worrying impacts.